Trends in Infectious Diseases: Updates on Treatment & Prevention Strategies for HIV and HCV
Understanding the Growing Syndemic — Opioids, HCV, and HIV
Clinical Practice Guidelines
HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C
American Association for the Study of Liver Diseases (AASLD)/Infectious Diseases Society of America (IDSA), 2017 (last updated May 2018).
Considerations for Antiretroviral Use in Patients With Coinfections: Hepatitis C Virus/HIV Coinfection.
US Department of Health and Human Services (DHHS), 2017 (last updated October 2018).
Patients With HIV/HCV Coinfection.
American Association for the Study of Liver Diseases (AASLD)/Infectious Diseases Society of America (IDSA), 2017 (last updated May 2018).
Clinical Resources
A Guide to Comprehensive Hepatitis C Counseling and Testing.
Centers for Disease Control and Prevention (CDC).
Harm Reduction Coalition.
HEP Drug Interactions.
University of Liverpool (last reviewed September 2019).
Action and Advocacy
Center for Health Law and Policy Innovation (CHLPI)
CHLPI advocates for legal, regulatory, and policy reforms to improve the health of underserved populations. It has played a pivotal role in removing Medicaid restrictions on HCV treatment.
Hepatitis C: State of Medicaid Access
CHLPI and National Viral Hepatitis Roundtable (NVHR).
Hepatitis Education Project (HEP)
HEP provides support, education, advocacy, and direct services for people affected by hepatitis, and works to raise hepatitis awareness among patients, medical providers, and the general public.
National Viral Hepatitis Roundtable
National Viral Hepatitis Roundtable (NVHR) is a coalition working together to eliminate hepatitis B and C in the U.S. It offers practical online resources for practice management.
This page provides information regarding coding and billing for hepatitis services.
Implementing EMR Prompts for Baby Boomer Screening
This page provides a variety of resources for implementing clinical decision support tools and/or HCV-testing prompts in electronic medical records.
This page provides or links to a variety of resources, including CARE-NAVIGATION TOOLS:
- HCV Treatment and Insurance Protocol: Prior Authorization Process
- Sample Appeals Letters (Templates)
Project ECHO (Extension for Community Healthcare Outcomes)
Project ECHO is a collaborative, telecommunications-based model of medical education and care management designed to train primary care clinicians to provide specialty care in rural and underserved communities.
Substance Abuse and Mental Health Services Administration (SAMHSA): Locator Map
SAMHSA provides an interactive national map that facilitates identification of local resources and services for substance use and mental health disorders.
Patient Resources
Hepatitis C Information Center
American Liver Foundation.
The American Liver Foundation’s Hepatitis C Information Center website is a dedicated online information and resource center created in support of individuals impacted by HCV infection.
HepatitisC.net
HepatitisC.net is a website for people living with HCV that offers education, tools, and resources. Articles are written by people living with or cured of HCV, patient advocates, and medical providers.
Hepatitis C Questions and Answers for the Public
Centers for Disease Control and Prevention (CDC; last reviewed November 2018). The CDC is a division within the US Department of Health and Human Services (DHHS), the principal agency for protecting the health of all Americans. This patient-directed website addresses basics across the HCV clinical continuum.
Suggested Readings
Attitudes and potential barriers towards hepatitis C treatment in patients with and without HIV coinfection.
Allyn PR, et al. Int J STD AIDS. 2018;29(4):334-340.
Hepatitis C virus re-treatment in the era of direct-acting antivirals: projections in the USA.
Chhatwal J, et al. Aliment Pharmacol Ther. 2018;47(7):1023-1031.
Mechanisms of accelerated liver fibrosis progression during HIV infection.
Debes JD, et al. J Clin Transl Hepatol. 2016;4(4):328-335.
High rates of unprotected anal sex and use of generic direct-acting antivirals in a cohort of MSM with acute HCV infection.
Girometti N, et al. J Viral Hepat. 2019;26(6):627-634.
Medical and behavioral approaches to engage people who inject drugs into care for hepatitis C virus infection.
Gonzalez SA, et al. Addict Disord Their Treat. 2017;16(2 suppl 1):S1-S23.
Treatment of HCV in persons who inject drugs: treatment as prevention.
Grebely J, Dore GJ. Clin Liver Dis. 2017;9(4):77-80.
Changing the odds: motives for and barriers to reducing HCV-related sexual risk behavior among HIV-infected MSM previously infected with HCV.
Lambers F, et al. BMC Infect Dis. 2018;18(1):678.
Facilitators of HCV treatment adherence among people who inject drugs: a systematic qualitative review and implications for scale up of direct acting antivirals.
Rich ZC, et al. BMC Public Health. 2016;16:994.
Understanding the Growing Syndemic —Opioids, HCV, and HIV
Relevant Resources
The PCPs Role in Preventing HIV
What Do You Know About PrEP?
Optimizing Use of Clinical Evidence & Pharmacoeconomic Models in Managed Care
Advances in the Diagnosis and Treatment of Nonalcoholic Steatohepatitis
What Do You Know About PrEP?
Got it? Treat it!
The Critical Role of the Community Pharmacist
Bringing Local Communities Together to Eliminate Coinfection Through Knowledge and Partnerships.
Volume 1: Rapid ART Initiation: A New Addition to the HIV-Care Tool Box
The Emerging Role of the Diabetologist
Key Issues Impacting OB/GYN Practice
An Interactive Experience Highlighting Recent Clinical Advances
Hot Topics in HBV, HCV, and NASH
Emerging Concepts in Patient Management
Building Your Understanding to Combat a Growing Problem
Volume II: Expanding Evidence for the Role of Rapid ART Initiation in HIV Practice
Why It Matters in OB/GYN Practice Today
A Treater’s Guide to Optimizing Care in the Aging Patient with Comorbidities
How the Pharmacist Can Make a Difference
HIV Can Be Prevented— Are You Doing Your Part?
Rapid Start ART — A New Model for HIV Care
Appraising the Therapeutic Armamentarium in Moderate and Severe Disease
A PrEP Primer
The PCP’s Role in HCV Elimination
What the Pharmacist Needs to Know about PrEP
The Rapid ART Standard of Care: From Evidence to Healthcare Equity
Maximizing Your Role to Impact Patient Outcomes
Building Bridges to Reach People Who Inject Drugs With the Goal to Eliminate HCV
Benefits, Barriers, & Best Practices in an Advancing Field
Practical Solutions Across the Spectrum of Care
A PEP/PrEP Training Guide for Pharmacists
An Interactive Learning Experience
A Focus on Clinical Evidence and Guideline Recommendations
A Critical Step Toward HCV Elimination
Considering the Patient, the Provider, and the Science
A Multidisciplinary Online Mini-Curriculum
Volume 1: A Guided Tour of the Evidence Driving Selection of First-line Advanced Therapies in Moderate to Severe IBD
Debates and Discussions about Monoclonal Antibody Therapies
An Update on Monoclonal Antibody Therapies
Establishing Clinical Readiness Through Mentored Learning
Interdisciplinary Strategies for Adult and Pediatric Patients
Interdisciplinary Management of Eosinophilic Esophagitis and Hereditary Angioedema
A Multidisciplinary Look at Early Diagnosis and Management
Recent Developments in Anti-SARS-CoV-2 Monoclonal Antibodies for Treatment
Best Practices for Diagnosis and Management
An Update on Best Practices
New Avenues to Pre-Exposure Prophylaxis
An Updated Clinician’s Guide to Assessment and Management
What the Pharmacist Needs to Know
A Look at the Changing HIV Playing Field
A “How To” Series Spanning Policy to Practice
Test Your Mastery!
Building Bridges to Reach People who Inject Drugs with the Goal of Employing PrEP for HIV Prevention
Bringing HIV Prevention to a New Level
Optimizing HIV Prevention in Primary Care
